Informations

Stand number

C78

Exhibition class

M: Medicine – Surgery – Orthopaedics – Material for disabled

Technical description

Use of monoclonal antibodies to target the protein LANCL1 to treat liver cancer. Targeting LANCL1 protein on the cell surface of human liver tumor-initiating cells blocks the initiation and growth of liver tumors.

Simplified description

Scientists are developing a new liver cancer treatment using special proteins called monoclonal antibodies. These antibodies target a specific protein on cancer cells, stopping tumors from starting and growing. This approach could lead to more effective treatments for liver cancer.